Global Arthritis Monoclonal Antibodies Market By Segmentation | Global Arthritis Monoclonal Antibodies Industry Volume, Value, Trends, Size, Share, Sales, and Key Players Revenue Analysis Report 2021-2026

Published: NOV 2020  |  Report ID: 064  | Pages: 150

Arthritis Monoclonal Antibodies Market Growth and Forecast (2021-2026):

The Global Arthritis Monoclonal Antibodies Market is expected to decline from $46.48 billion in 2019 to $45.18 billion in 2020 at a compound annual growth rate (CAGR) of -2.8%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $56.05 billion in 2023 at a CAGR of 7.45%.

Arthritis Monoclonal Antibodies Market is Segmented by Drug into Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima, by Application into Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Others.

Arthritis Monoclonal Antibodies Market Segmentation Analysis:

By Drug:

  • Remicade
  • Humira
  • Enbrel
  • Rituxan
  • Orencia
  • Actemra
  • Simponi
  • Cimzia
  • Remsima

By Application:

  • Rheumatoid Arthritis
  • Osteoarthritis
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Fibromyalgia
  • Others

Geographical Analysis:

North America

  • U.S
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico

Middle East and Arica

  • Middle-East
  • Africa

Key Players in the Market:

Major Key Players in the Global Arthritis Monoclonal Antibodies Market are

  • Johnson & Johnson
  • Roche
  • Novartis,
  • Pfizer Inc
  • AbbVie Inc
  • Amgen Inc
  • Genentech
  • GSK
  • AstraZeneca PLC
  • Mylan N.V
  • Bristol Myers Squibb
  • Eli Lily and Company

          1. Preface             

                   1.1 Market Definition and Scope    

                   1.2 Base Currency, Base Year and Forecast Periods   

                   1.3 Key Research Objectives 

                   1.4 Research Highlights        

          2. General Study Assumptions                 

          3. Research Methodology                

                   3.1 Introduction  

                   3.2 Secondary Research        

                   3.3 Primary Research   

                   3.4 Analysis Design     

                   3.5 Study Timeline       

          4. Market Dynamics               

                   4.1 Drivers 

                   4.2 Restraints      

                   4.3 Opportunities         

                   4.4 Market Trends        

          5. Supply Chain Analysis                 

          6. Company Strategy Analysis                  

                   6.1 Merger and Acquisition Analysis       

                   6.2 Agreements, Collaborations and Joint Ventures  

                   6.3 Regional Presence  

                   6.4 New Product Launches    

          7. Market Outlook                  

                   7.1 Technological Advancement    

                   7.2 Pricing Analysis      

                   7.3 Epidemiology          

                   7.4 Product Landscape Analysis (Brand Tracking Analysis & Pipeline Analysis)          

          8. Market Segmentation                  

                   8.1 Overview       

                   8.2 Global Arthritis Monoclonal Antibodies Market, By Drug, forecast year 2021-2026         

                             8.2.1 Remicade

                             8.2.2 Humira

                             8.2.3 Enbrel

                             8.2.4 Rituxan

                             8.2.5 Orencia

                             8.2.6 Actemra

                             8.2.7 Simponi

                             8.2.8 Cimzia

                             8.2.9 Remsima

                             8.2.10 Market Size Estimations & Forecasts (2021-2026)

                             8.2.11 Y-o-Y Growth Analysis

                             8.2.12 Market Investment Opportunities Analysis

                   8.3 Global Arthritis Monoclonal Antibodies Market, By Application, forecast year 2021-2026 

                             8.3.1 Rheumatoid Arthritis

                             8.3.2 Osteoarthritis

                             8.3.3 Psoriatic Arthritis

                             8.3.4 Ankylosing Spondylitis

                             8.3.5 Fibromyalgia

                             8.3.6 Others

                             8.3.7 Market Size Estimations & Forecasts (2021-2026)

                             8.3.8 Y-o-Y Growth Analysis

                             8.3.9 Market Investment Opportunities Analysis

          9. Market Regional and Country Analysis, Forecast 2021-2026        

                   9.1 Overview       

                    9.2 Regional Trends     

                   9.3 Impact Analysis      

                   9.4 Key Findings 

                   9.5 Global Arthritis Monoclonal Antibodies Market,  by Region, 2021-2026 

                             9.5.1 By Drug

                             9.5.2 By Application

          10. Competitive Landscape Analysis                 

                   10.1 Market Player        

                             10.1.1 Company Revenue

                             10.1.2 Business unit

                             10.1.3 Product Mapping

                             10.1.4 Geographical Locations

                   10.2 Company Share Analysis        

          11. Strategic Analysis            

                   11.1 PESTLE analysis    

                   11.2 Porter’s Five analysis     

                             11.2.1 Bargaining Power of Suppliers

                             11.2.2 Bargaining Power of Consumers

                             11.2.3 Threat of New Entrants

                             11.2.4 Threat of Substitute Products and Services

                             11.2.5 Competitive Rivalry within the Industry

          12. Company Profiles             

                   12.1 Johnson & Johnson        

                             12.1.1 Overview

                             12.1.2 Product Portfolio

                             12.1.3 Financial Details

                             12.1.4 SWOT Analysis

                             12.1.5 Market Strategies

                   12.2 Roche 

                   12.3 Novartis       

                   12.4 Pfizer Inc     

                   12.5 AbbVie Inc  

                   12.6 Amgen Inc  

                   12.7 Genentech  

                   12.8 GSK    

                   12.9 AstraZeneca PLC  

                   12.10 Mylan N.V 

          13. Market Guidance              

          14. Appendix                

Note: Information provided by you stored on our secure servers. We Protect Your Privacy.